BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32592916)

  • 21. Unexplained recurrent miscarriages: predictive value of immune biomarkers and immunomodulatory therapies for live birth.
    Kolanska K; Dabi Y; Dechartres A; Cohen J; Ben Kraiem Y; Selleret L; Mathieu d'Argent E; Placais L; Cheloufi M; Johanet C; Rosefort A; Bornes M; Suner L; Delhommeau F; Ledée N; Chabbert Buffet N; Darai E; Antoine JM; Fain O; Kayem G; Mekinian A
    Am J Reprod Immunol; 2021 Aug; 86(2):e13425. PubMed ID: 33772927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intralipid infusion at time of embryo transfer in women with history of recurrent implantation failure: A systematic review and meta-analysis.
    Rimmer MP; Black N; Keay S; Quenby S; Al Wattar BH
    J Obstet Gynaecol Res; 2021 Jun; 47(6):2149-2156. PubMed ID: 33754451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Number and sequence of preceding miscarriages and maternal age for the prediction of antiphospholipid syndrome in women with recurrent miscarriage.
    van den Boogaard E; Cohn DM; Korevaar JC; Dawood F; Vissenberg R; Middeldorp S; Goddijn M; Farquharson RG
    Fertil Steril; 2013 Jan; 99(1):188-192. PubMed ID: 23043688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The impact of the number of previous miscarriages on embryo euploid rate and pregnancy outcomes in patients with unexplained recurrent pregnancy loss].
    Zhao ST; Liu YB; Zhang Q; Ni TX; Yan JH
    Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(36):2874-2880. PubMed ID: 37726994
    [No Abstract]   [Full Text] [Related]  

  • 25. Embryo loss pattern is predominant in miscarriages with normal chromosome karyotype among women with repeated miscarriage.
    Morikawa M; Yamada H; Kato EH; Shimada S; Yamada T; Minakami H
    Hum Reprod; 2004 Nov; 19(11):2644-7. PubMed ID: 15298979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of intralipid infusions on anti-trophoblast antibody (ATAb)-activities in patients with recurrent pregnancy loss: An observational report.
    Rogenhofer N; Mahner S; von Hasselbach YL; Thaler CJ
    Am J Reprod Immunol; 2022 Feb; 87(2):e13506. PubMed ID: 34935238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of paternal lymphocyte immunotherapy and potential biomarker mixed lymphocyte reaction-blocking factor in an Argentinian cohort of women with unexplained recurrent spontaneous abortion and unexplained infertility.
    Fainboim L; Belén S; González V; Fernández P
    Am J Reprod Immunol; 2021 Aug; 86(2):e13422. PubMed ID: 33730440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
    Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of reproductive outcome, including the pattern of loss, between couples with chromosomal abnormalities and those with unexplained repeated miscarriages.
    Flynn H; Yan J; Saravelos SH; Li TC
    J Obstet Gynaecol Res; 2014 Jan; 40(1):109-16. PubMed ID: 24033546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis.
    Potdar N; Gelbaya TA; Konje JC; Nardo LG
    Hum Reprod Update; 2013; 19(6):674-84. PubMed ID: 23912476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spontaneous first trimester miscarriage rates per woman among parous women with 1 or more pregnancies of 24 weeks or more.
    Cohain JS; Buxbaum RE; Mankuta D
    BMC Pregnancy Childbirth; 2017 Dec; 17(1):437. PubMed ID: 29272996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proportion of Cytotoxic Peripheral Blood Natural Killer Cells and T-Cell Large Granular Lymphocytes in Recurrent Miscarriage and Repeated Implantation Failure: Case-Control Study and Meta-analysis.
    Kolanska K; Suner L; Cohen J; Ben Kraiem Y; Placais L; Fain O; Bornes M; Selleret L; Delhommeau F; Feger F; Mathieu d'Argent E; Darai E; Chabbert-Buffet N; Antoine JM; Kayem G; Mekinian A
    Arch Immunol Ther Exp (Warsz); 2019 Aug; 67(4):225-236. PubMed ID: 31147723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perinatal outcomes in a subsequent pregnancy among women who have experienced recurrent miscarriage: a retrospective cohort study.
    Field K; Murphy DJ
    Hum Reprod; 2015 May; 30(5):1239-45. PubMed ID: 25759495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Midluteal serum progesterone concentration does not predict the outcome of pregnancy in women with unexplained recurrent miscarriage.
    Yan J; Liu F; Yuan X; Saravelos SH; Cocksedge K; Li TC
    Reprod Biomed Online; 2013 Feb; 26(2):138-41. PubMed ID: 23273755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progesterone supplementation in women with otherwise unexplained recurrent miscarriages.
    Hussain M; El-Hakim S; Cahill DJ
    J Hum Reprod Sci; 2012 Sep; 5(3):248-51. PubMed ID: 23533097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intralipid therapy for recurrent implantation failure: new hope or false dawn?
    Shreeve N; Sadek K
    J Reprod Immunol; 2012 Jan; 93(1):38-40. PubMed ID: 22196107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the Utility of Intralipid Infusion to Improve Live Birth Rates in Patients with Recurrent Pregnancy Loss or Recurrent Implantation Failure.
    Martini AE; Jasulaitis S; Fogg LF; Uhler ML; Hirshfeld-Cytron JE
    J Hum Reprod Sci; 2018; 11(3):261-268. PubMed ID: 30568356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid Peroxidase Antibodies and Prospective Live Birth Rate: A Cohort Study of Women with Recurrent Pregnancy Loss.
    Bliddal S; Feldt-Rasmussen U; Rasmussen ÅK; Kolte AM; Hilsted LM; Christiansen OB; Nielsen CH; Nielsen HS
    Thyroid; 2019 Oct; 29(10):1465-1474. PubMed ID: 31407629
    [No Abstract]   [Full Text] [Related]  

  • 39. Effectiveness and potential mechanisms of intralipid in treating unexplained recurrent spontaneous abortion.
    Meng L; Lin J; Chen L; Wang Z; Liu M; Liu Y; Chen X; Zhu L; Chen H; Zhang J
    Arch Gynecol Obstet; 2016 Jul; 294(1):29-39. PubMed ID: 26671484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Randomized Trial of Progesterone in Women with Recurrent Miscarriages.
    Coomarasamy A; Williams H; Truchanowicz E; Seed PT; Small R; Quenby S; Gupta P; Dawood F; Koot YE; Bender Atik R; Bloemenkamp KW; Brady R; Briley AL; Cavallaro R; Cheong YC; Chu JJ; Eapen A; Ewies A; Hoek A; Kaaijk EM; Koks CA; Li TC; MacLean M; Mol BW; Moore J; Ross JA; Sharpe L; Stewart J; Vaithilingam N; Farquharson RG; Kilby MD; Khalaf Y; Goddijn M; Regan L; Rai R
    N Engl J Med; 2015 Nov; 373(22):2141-8. PubMed ID: 26605928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.